Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is manufactured by Eli Lilly, an American pharmaceutical company, at production facilities in the United States and Ireland. Every pen dispensed through the UK's licensed supply chain originates from those regulated sites and meets MHRA standards before reaching patients. You've probably ended up here because you spotted a dramatically cheaper listing somewhere online and wondered whether it could genuinely be the same product made in the same place. It's a reasonable question — and the answer has direct safety implications for anyone considering treatment with a prescription medicine.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Imagine you're a few weeks into researching weight-loss treatment. You've read about Mounjaro, you know the NHS waiting list is long, and you've started comparing private providers. Then a social-media ad appears offering what looks like the same KwikPen at a fraction of the price, sometimes with a note about it being 'imported' or 'sourced internationally'. The question that follows is completely natural: does it matter where it was made?
It matters enormously. Mounjaro is manufactured by Eli Lilly at facilities that operate under strict pharmaceutical quality systems, in the United States and at Eli Lilly's manufacturing operations in Ireland. Those sites are subject to regulatory oversight from agencies including the US FDA and the European Medicines Agency, and Eli Lilly supplies the UK market through an authorised distribution chain that the MHRA monitors. Every genuine pen that a GPhC-registered pharmacy dispenses in the UK has travelled through that chain and carries the product specifications approved when Mounjaro received its UK licence.
A pen sourced outside that chain (regardless of how it looks, what the label says, or which country of manufacture is claimed) has not gone through those checks. The MHRA has confirmed that counterfeit weight-loss pens have been seized in the UK containing insulin and other substances that can cause serious harm. In October 2025, enforcement officers raided the first known illicit manufacturing site producing fake tirzepatide pens, located in Northampton. The volume of illegally traded weight-loss medicines seized across 2025 reached approximately 20 million doses with an estimated street value of around £45 million. You can read the MHRA's public guidance on fake weight-loss pens and how to stay safe directly on GOV.UK.
If you want to understand the story behind who made Mounjaro, it goes back to Eli Lilly, one of the world's largest and oldest pharmaceutical manufacturers, founded in 1876. The company developed tirzepatide (Mounjaro's active ingredient) and holds the global licence for it. For UK patients, that matters because Eli Lilly's authorised suppliers are the only legitimate source of genuine product.
The KwikPen format dispensed in the UK contains four weekly doses in a single pre-filled device, in strengths from 2.5 mg up to 15 mg. Tirzepatide itself is a synthetic peptide, a precisely constructed molecule that activates both GIP and GLP-1 receptors involved in appetite regulation and blood-sugar control. If you're curious about the ingredient profile in more depth, the full breakdown of what Mounjaro contains covers excipients, the delivery mechanism and how the molecule works.
For a GPhC-registered pharmacy to dispense Mounjaro legally, it must source stock from Lilly's authorised UK supply chain. At nume, that is exactly how we operate, you can read more about what makes a Mounjaro provider reputable in the UK if you want a checklist before choosing where to go. Pharmacies sourcing through any other route cannot guarantee the product's origin, storage history or authenticity.
Country of manufacture is only one part of the picture. Even genuine Mounjaro can be compromised if it hasn't been stored correctly, tirzepatide requires refrigeration between 2°C and 8°C throughout transit, and deviations from that window may affect the medicine's integrity. A pen that left a licensed manufacturing site in Ireland but then sat in an uncontrolled warehouse or was shipped unrefrigerated has not reached you in the condition it left.
This is why the supply chain matters as much as the factory. The NHS sets out clearly that these are prescription-only medicines requiring clinical assessment, the NHS tirzepatide page is a useful starting reference for what legitimate treatment looks like. A pharmacy registered with the GPhC is legally required to maintain cold-chain storage and dispense only against a valid prescription; you can verify any UK online pharmacy on the GPhC register before placing an order.
Red flags that suggest a seller is operating outside the legitimate supply chain include: offering Mounjaro without requiring a prescription or clinical consultation, prices significantly below the market range (which has typically run from around £149 to £375 per month for private supply since Eli Lilly revised UK list prices in September 2025), or vague answers about where stock is sourced. If a seller is evasive about which company makes Mounjaro and holds its global licence, that itself is a warning sign worth taking seriously. For a broader look at how Mounjaro pricing works across UK providers, that page covers what a legitimate private price should include. If you come across a seller that seems suspicious, the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk lets you report suspect medicines and sellers.
If you're thinking about starting treatment and want a prescriber to review your situation properly, the full Mounjaro guide on our site is a good place to begin, and our free consultation connects you with a GPhC-registered Independent Prescriber the same day you apply. A real clinician reads your answers; no automated decision-making involved.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.